文献速递心外重症与机械循环支持

肥胖对左心室辅助装置患者再入院的影响

Impact of Obesity on Readmission in Patients With Left Ventricular Assist Devices.
PubMed 文献 · Ann Thorac Surg · 2018-02-15

该研究回顾性分析了2004年5月至2014年12月本中心350例连续接受连续流左心室辅助装置患者的住院数据,发现再入院负担在支持治疗最初几个月最高,但再入院次数不影响生存;体重指数每增加1个单位与总体再入院率增加相关,体重指数≥30 kg/m²的患者因装置故障和右心衰竭再入院的风险增加。

要点

  • 30天再入院率为21.7%,264次再入院(41.1%)发生在支持治疗最初6个月内。
  • 再入院次数对生存无不良影响(HR 1.03;95%CI 0.92-1.17;P=0.58)。
  • 体重指数每增加1个单位,总体再入院率增加1.029倍(P=0.041)。

核心结论

  • 连续流左心室辅助装置支持治疗最初几个月再入院负担最高,但生存不受影响。
  • 体重指数升高的患者因装置故障和右心衰竭再入院的风险增加。

研究设计与样本

  • 回顾性分析本中心2004年5月至2014年12月350例连续接受连续流左心室辅助装置患者的住院数据。
  • 采用总时间限制模型估计再入院的风险比,采用Nelson非参数方法估计每种再入院原因的平均累积函数。

主要发现

  • 平均年龄57±13岁,82.6%接受HeartMate II(Abbott Laboratories, Chicago, IL),26.3%为destination therapy。
  • 30天再入院率为21.7%,264次再入院(41.1%)发生在支持治疗最初6个月内。
  • 3年内再入院主要原因依次为出血(平均累积事件每人0.74次)、感染(0.7次)、装置故障(0.52次)、心律失常(0.3次)和右心衰竭(0.28次)。
  • 再入院次数对生存无不良影响(HR 1.03;95%CI 0.92-1.17;P=0.58)。
  • 体重指数每增加1个单位与总体再入院率增加1.029倍相关(P=0.041);体重指数≥30 kg/m²的患者因装置故障(P=0.008)和右心衰竭(P=0.03)再入院增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hospital readmissions have an adverse effect on the quality of life in patients with end-stage heart failure. We examined the temporal pattern, predictors, and outcomes of readmission in continuous flow left ventricular assist device-supported patients. METHODS: We retrospectively reviewed inpatient data of 350 consecutive patients who received a continuous-flow left ventricular assist device at our center between May 2004 and December 2014. A total time-restricted model was used to estimate hazard ratios for readmission, and the Nelson nonparametric method was used to estimate mean cumulative function for each cause of readmission. RESULTS: The mean age was 57 ± 13 years, 82.6% received a HeartMate II (Abbott Laboratories, Chicago, IL), and 26.3% were destination therapy. The 30-day readmission rate was 21.7%, and 264 readmissions (41.1%) occurred within the first 6 months of support. The leading cause of readmission was bleeding (0.74 mean cumulative events per person), followed by infection (0.7), device failure (0.52), arrhythmia (0.3), and right heart failure (0.28) at 3 years. The number of readmissions did not have an adverse effect on survival (hazard ratio, 1.03; 95% confidence interval, 0.92 to 1.17; p = 0.58). Increase in each body mass index unit was associated with 1.029 times the rate of overall readmission (p = 0.041). Patients with a body mass index of 30 kg/m2 or higher had increased readmissions for device failure (p = 0.008) and right heart failure (p = 0.03). CONCLUSIONS: Readmission burden is highest during the first few months of continuous-flow left ventricular assist device support, but survival is not affected. Patients with an elevated body mass index are at increased risk for readmissions for device failure and right heart failure.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Han J, Mauro CM, Kurlansky PA, et al. Impact of Obesity on Readmission in Patients With Left Ventricular Assist Devices. Ann Thorac Surg. 2018. PMID: 29397927. doi:10.1016/j.athoracsur.2017.10.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。